• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国在 COVID-19 大流行期间对临床脆弱人群实施屏蔽政策的理由:一项定性研究。

Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study.

机构信息

Swansea University Medical School, Swansea University, Swansea, UK

Swansea University Medical School, Swansea University, Swansea, UK.

出版信息

BMJ Open. 2023 Aug 4;13(8):e073464. doi: 10.1136/bmjopen-2023-073464.

DOI:10.1136/bmjopen-2023-073464
PMID:37541747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10407356/
Abstract

INTRODUCTION

Shielding aimed to protect those predicted to be at highest risk from COVID-19 and was uniquely implemented in the UK during the first year of the pandemic from March 2020. As the first stage in the EVITE Immunity evaluation (Effects of shielding for vulnerable people during COVID-19 pandemic on health outcomes, costs and immunity, including those with cancer:quasi-experimental evaluation), we generated a logic model to describe the programme theory underlying the shielding intervention.

DESIGN AND PARTICIPANTS

We reviewed published documentation on shielding to develop an initial draft of the logic model. We then discussed this draft during interviews with 13 key stakeholders involved in putting shielding into effect in Wales and England. Interviews were recorded, transcribed and analysed thematically to inform a final draft of the logic model.

RESULTS

The shielding intervention was a complex one, introduced at pace by multiple agencies working together. We identified three core components: agreement on clinical criteria; development of the list of people appropriate for shielding; and communication of shielding advice. In addition, there was a support programme, available as required to shielding people, including food parcels, financial support and social support. The predicted mechanism of change was that people would isolate themselves and so avoid infection, with the primary intended outcome being reduction in mortality in the shielding group. Unintended impacts included negative impact on mental and physical health and well-being. Details of the intervention varied slightly across the home nations of the UK and were subject to minor revisions during the time the intervention was in place.

CONCLUSIONS

Shielding was a largely untested strategy, aiming to mitigate risk by placing a responsibility on individuals to protect themselves. The model of its rationale, components and outcomes (intended and unintended) will inform evaluation of the impact of shielding and help us to understand its effect and limitations.

摘要

简介

shielding 旨在保护那些预测在 COVID-19 中风险最高的人,在 2020 年大流行的第一年,英国是唯一实施这种保护的国家。作为 EVITE 免疫评估(COVID-19 大流行期间对脆弱人群进行屏蔽以保护健康、成本和免疫的效果,包括癌症患者:准实验评估)的第一阶段,我们生成了一个逻辑模型来描述屏蔽干预背后的计划理论。

设计和参与者

我们回顾了有关屏蔽的已发表文件,以开发逻辑模型的初始草案。然后,我们在与威尔士和英格兰实施屏蔽的 13 名关键利益相关者的访谈中讨论了这一草案。访谈进行了录音、转录,并进行了主题分析,以形成逻辑模型的最终草案。

结果

屏蔽干预措施是一个复杂的措施,由多个机构共同快速引入。我们确定了三个核心组成部分:对临床标准的协议;制定适合屏蔽的人员名单;以及屏蔽建议的沟通。此外,还有一个支持计划,根据需要向屏蔽人员提供食品包、经济支持和社会支持。预期的变化机制是人们将自我隔离,从而避免感染,屏蔽组的主要预期结果是死亡率降低。意外影响包括对心理健康和幸福感的负面影响。干预措施的细节在英国的不同地区略有不同,并在干预措施实施期间进行了微小的修订。

结论

屏蔽是一种未经充分测试的策略,旨在通过让个人承担保护自己的责任来降低风险。该模型的原理、组成部分和结果(预期和非预期)将为评估屏蔽的影响提供信息,并帮助我们理解其效果和局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8213/10407356/2b3678e990a5/bmjopen-2023-073464f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8213/10407356/2b3678e990a5/bmjopen-2023-073464f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8213/10407356/2b3678e990a5/bmjopen-2023-073464f01.jpg

相似文献

1
Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study.英国在 COVID-19 大流行期间对临床脆弱人群实施屏蔽政策的理由:一项定性研究。
BMJ Open. 2023 Aug 4;13(8):e073464. doi: 10.1136/bmjopen-2023-073464.
2
Evaluation of the shielding initiative in Wales (EVITE Immunity): protocol for a quasiexperimental study.威尔士屏蔽计划评估(EVITE 免疫):一项准实验研究的方案。
BMJ Open. 2022 Sep 8;12(9):e059813. doi: 10.1136/bmjopen-2021-059813.
3
The cost of implementing the COVID-19 shielding policy in Wales.威尔士实施 COVID-19 保护政策的成本。
BMC Public Health. 2023 Nov 26;23(1):2342. doi: 10.1186/s12889-023-17169-3.
4
Exploring the impact of shielding advice on the wellbeing of individuals identified as clinically extremely vulnerable amid the COVID-19 pandemic: a mixed-methods evaluation.探讨在 COVID-19 大流行期间,针对被临床认定为极脆弱的个体的屏蔽建议对其健康的影响:一项混合方法评估。
BMC Public Health. 2022 Nov 22;22(1):2145. doi: 10.1186/s12889-022-14368-2.
5
Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study.英国公共卫生保护政策在威尔士 COVID-19 大流行期间保护了临床极度脆弱人群吗?EVITE 免疫关联数据回顾性研究结果。
Public Health. 2023 May;218:12-20. doi: 10.1016/j.puhe.2023.02.008. Epub 2023 Feb 15.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Intersecting factors of disadvantage and discrimination and their effect on daily life during the coronavirus pandemic: the CICADA-ME mixed-methods study.新冠疫情期间不利因素与歧视的交叉影响及其对日常生活的作用:CICADA-ME混合方法研究
Health Soc Care Deliv Res. 2025 Feb;13(2):1-185. doi: 10.3310/KYTF4381.
8
An evaluation of the national testing response during the COVID-19 pandemic in England: a multistage mixed-methods study protocol.评估英格兰在 COVID-19 大流行期间的全国检测应对情况:一项多阶段混合方法研究方案。
BMJ Open. 2024 Jun 16;14(6):e077271. doi: 10.1136/bmjopen-2023-077271.
9
Qualitative interview study of rheumatology patients' experiences of COVID-19 shielding to explore the physical and psychological impact and identify associated support needs.对风湿病患者新冠病毒隔离经历的定性访谈研究,以探讨其身体和心理影响并确定相关支持需求。
BMJ Open. 2024 Apr 22;14(4):e075871. doi: 10.1136/bmjopen-2023-075871.
10
Effects on mortality of shielding clinically extremely vulnerable patients in Liverpool, UK, during the COVID-19 pandemic.英国利物浦在 COVID-19 大流行期间对临床极脆弱患者进行防护对死亡率的影响。
Public Health. 2023 Sep;222:54-59. doi: 10.1016/j.puhe.2023.06.037. Epub 2023 Jul 5.

引用本文的文献

1
Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance.免疫抑制人群 COVID-19 死亡率的差异:加强疾病监测的系统评价和荟萃分析。
J Infect. 2024 Mar;88(3):106110. doi: 10.1016/j.jinf.2024.01.009. Epub 2024 Jan 30.
2
The cost of implementing the COVID-19 shielding policy in Wales.威尔士实施 COVID-19 保护政策的成本。
BMC Public Health. 2023 Nov 26;23(1):2342. doi: 10.1186/s12889-023-17169-3.

本文引用的文献

1
Critical weaknesses in shielding strategies for COVID-19.新型冠状病毒肺炎防护策略中的关键弱点。
PLOS Glob Public Health. 2022 Apr 26;2(4):e0000298. doi: 10.1371/journal.pgph.0000298. eCollection 2022.
2
Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study.英国公共卫生保护政策在威尔士 COVID-19 大流行期间保护了临床极度脆弱人群吗?EVITE 免疫关联数据回顾性研究结果。
Public Health. 2023 May;218:12-20. doi: 10.1016/j.puhe.2023.02.008. Epub 2023 Feb 15.
3
Evaluation of the shielding initiative in Wales (EVITE Immunity): protocol for a quasiexperimental study.
威尔士屏蔽计划评估(EVITE 免疫):一项准实验研究的方案。
BMJ Open. 2022 Sep 8;12(9):e059813. doi: 10.1136/bmjopen-2021-059813.
4
Validating the QCOVID risk prediction algorithm for risk of mortality from COVID-19 in the adult population in Wales, UK.验证 QCOVID 风险预测算法在英国威尔士成年人群中 COVID-19 死亡率风险的预测能力。
Int J Popul Data Sci. 2022 Feb 15;5(4):1697. doi: 10.23889/ijpds.v5i4.1697. eCollection 2020.
5
COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency Cohort.全国免疫缺陷队列中新冠病毒疫苗的接种情况及有效性
J Clin Immunol. 2022 May;42(4):728-731. doi: 10.1007/s10875-022-01223-7. Epub 2022 Feb 11.
6
'We thank you for your sacrifice': Clinical vulnerability, shielding and biosociality in the UK's Covid-19 response.“我们感谢您的牺牲”:英国应对新冠疫情中的临床脆弱性、防护与生物社会性
Biosocieties. 2023;18(1):218-240. doi: 10.1057/s41292-021-00266-0. Epub 2022 Jan 22.
7
National responses to covid-19: drivers, complexities, and uncertainties in the first year of the pandemic.国家对 COVID-19 的应对措施:大流行第一年的驱动因素、复杂性和不确定性。
BMJ. 2021 Nov 28;375:e068954. doi: 10.1136/bmj-2021-068954.
8
A Systematic Review and Meta-Analysis of Inpatient Mortality Associated With Nosocomial and Community COVID-19 Exposes the Vulnerability of Immunosuppressed Adults.一项系统评价和荟萃分析显示,住院患者的院内和社区获得性 COVID-19 暴露与免疫抑制成年人的脆弱性相关。
Front Immunol. 2021 Oct 6;12:744696. doi: 10.3389/fimmu.2021.744696. eCollection 2021.
9
The impact of the COVID-19 pandemic on mental health and well-being of people living with a long-term physical health condition: a qualitative study.2019年冠状病毒病大流行对患有长期身体健康状况者心理健康和幸福感的影响:一项定性研究
BMC Public Health. 2021 Oct 7;21(1):1801. doi: 10.1186/s12889-021-11751-3.
10
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance.制定和评估复杂干预措施的新框架:对医学研究理事会指南的更新。
BMJ. 2021 Sep 30;374:n2061. doi: 10.1136/bmj.n2061.